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1. Introduction
The rapid growth of the biomedical engi-
neering field in the past few decades has 
enabled the emergence of bionic organs, a 
highly serviceable asset for replicating spe-
cific organ functions and increasing the 
accuracy of in vitro test models, with the 
aim to eventually replace native organs. 
To create bionic organs, high-precision 
and functional electronic devices need to 
be integrated into viable engineered bio-
logical systems. While the two stem from 
fully disparate classes of materials and 
fabrication techniques, recent research 
has been focused on closing this gap by 
introducing techniques and protocols opti-
mized for co-fabrication of biocompatible 
and implantable bionic organs.[1] The cur-
rent state of development of bionic organs 
is still impeded by several challenges, par-
ticularly in mimicking the complexity of 
tissue or organ structure and functionality. 
The intricate heterogeneity in biological 
structures and the physical properties 
of human organs has intrigued a need 
Advances in biomanufacturing techniques have opened the doors to 
recapitulate human sensory organs such as the nose and ear in vitro 
with adequate levels of functionality. Such advancements have enabled 
simultaneous targeting of two challenges in engineered sensory organs, 
especially the nose: i) mechanically robust reconstruction of the nasal 
cartilage with high precision and ii) replication of the nose functionality: 
odor perception. Hybrid nasal organs can be equipped with remarkable 
capabilities such as augmented olfactory perception. Herein, a proof-of-
concept for an odor-perceptive nose-like hybrid, which is composed of a 
mechanically robust cartilage-like construct and a biocompatible biosensing 
platform, is proposed. Specifically, 3D cartilage-like tissue constructs 
are created by multi-material 3D bioprinting using mechanically tunable 
chondrocyte-laden bioinks. In addition, by optimizing the composition of 
stiff and soft bioinks in macro-scale printed constructs, the competence of 
this system in providing improved viability and recapitulation of chondrocyte 
cell behavior in mechanically robust 3D constructs is demonstrated. 
Furthermore, the engineered cartilage-like tissue construct is integrated with 
an electrochemical biosensing system to bring functional olfactory sensations 
toward multiple specific airway disease biomarkers, explosives, and toxins 
under biocompatible conditions. Proposed hybrid constructs can lay the 
groundwork for functional bionic interfaces and humanoid cyborgs.
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for multi-material and multi-cellular hybrid designs. Various 
studies have introduced a well-established protocol to fabricate 
macro-scale tissues and organ-like constructs with resemblance 
to the biological structure and physical properties of the target 
tissue or organ.[2] However, tissue-specific functionalities such 
as sensory and auditory capabilities, olfaction, and vision are 
often chiefly missing from the replicas.
Among the various sensory organs in the body, the nose has 
a great potential to be targeted for bionic organ engineering, 
as both the tissue and function can be mimicked through 
tissue engineering techniques and odor-detecting electronic 
devices. The nasal cartilage tissue is majorly composed of 
hyaline cartilage, which consists of densely packed collagen 
and proteoglycan-based extracellular matrix (ECM) embedded 
with chondrocytes.[3] Moreover, it has a relatively simple 
structure along with mechanically robust and elastic proper-
ties compared to other tissues in the body.[4] These attributes 
facilitate engineering 3D nasal cartilage tissues using a com-
bination of biomaterials and microfabrication techniques. On 
the other hand, the sensing and olfactory system in this organ 
is endowed with intricate and unique physical and biological 
properties. With the ability to discriminate thousands of volatile 
compounds and chemical structures, the olfactory system plays 
an important role in assisting humans with perception of the 
outer environment. Through studying the chemical structure 
of the olfactory receptors (ORs) and their function, the specific 
binding of each of these proteins to odorant compounds with 
similar chemical structures can be achieved, paving the way for 
engineering an odor-perceptible artificial nose.
Two distinct research communities have dedicated their 
efforts to nose organ reconstruction. In the first group, where 
the focus is on emulating the function of the nose via elec-
tronic nose sensor devices, the biological features and physical 
functions of a native nose are neglected.[5] As such, interfacing 
the electronic sensing system with the tissue is also ignored. 
The electronic noses often consist of a sensing unit, which is 
immobilized with odor-specific receptors which capture the 
target molecule and transduce the binding event to an elec-
trical signal. Sensing mechanisms such as field effect transis-
tors (FETs), quartz crystal microbalance, and electrochemical 
(EC) sensor units have proved successful.[6] Electronic noses 
have been developed for a range of applications to detect toxic 
gases,[7] food quality monitoring[8] as well as being used as a 
diagnostic tool for diseases such as pneumonia[9] and lung 
cancer.[10] An obstructive factor in integrating the commonly 
developed sensor devices with tissues is pertained to the harsh 
conditions in which the sensor devices operate. Moreover, selec-
tion of toxic chemicals (e.g., specific electrolytes) and electrode 
materials to improve the sensing capability can create a noncy-
tocompatible environment for most tissues.[11] The second com-
munity, on the other hand, has focused merely on modification 
or reconstruction of the nasal anatomy for cosmetic purposes, 
or for after the organ has been physically damaged (e.g., those 
caused by traumatic accidents). Given the structural features 
and replication feasibilities of the nasal organ, engineering and 
development of cartilage-mimicking tissues has proved practi-
cally successful in several studies.[12] Additionally, some groups 
in this category have targeted cartilage regeneration and tissue 
repair.[12c,13] The elaborate structure of the nasal passageway 
plays an integral part in conditioning air for olfaction and res-
piration. This conditioning includes precise controlling of the 
gaseous fluidic mechanics of the inhaled air and adjustments 
to humidity and temperature, and filtering and air flow charac-
teristics such as flow rate, intermittence, and regime (laminar, 
transitional, or turbulent).[14] Moreover, this structure allows 
the airflow velocity to be decreased near the olfactory epithe-
lium, facilitating full contact between gas molecules and the 
lined surface of the olfactory epithelium thus increasing the 
sensitivity of odor detection.[14c,15] To achieve enhanced artificial 
olfaction with close relevance to the native structure, such ana-
tomical elaborations should be integrated into the bioelectronic 
noses.
Here, we aim to bridge this gap between the two communi-
ties to create an effective biocompatible functional hybrid nose-
like tissue construct. Previously, a 3D printing–based approach 
was pursued to bring auditory functionality to auricular car-
tilage via developing a 3D-printed bionic ear.[16] Following a 
similar strategy, we are targeting the retention of olfaction 
to develop a hybrid nasal tissue. To the best of our knowl-
edge, there have not been any attempts toward the creation of 
a hybrid nasal tissue with the capability of odor sensing and 
olfactory system retention. Specifically, we have developed a 
chondrocyte-laden 3D-bioprinted cartilage-like construct with 
an electronic olfaction-mimetic biosensor. Employing 3D bio-
printing technology is especially beneficial in this approach as 
it allows for the creation of 3D hybrid platforms with desired 
geometries and high precision. While 3D printing parame-
ters can be readily engineered to fit the cellular environment 
requirements, the structure can be coupled with an electronic 
functional element to create a viable hybrid device.[16,17] More-
over, photo-crosslinkable hydrogel-based bioinks composed of 
gelatin methacryloyl (GelMA) and polyethylene glycol dimeth-
acrylate (PEGDMA) can form a mechanically robust and 
biocompatible 3D microenvironment to support cartilage cell 
growth and their differentiation by tuning the mechanical prop-
erties of the bioinks. As such, two distinct bioinks with stiff and 
soft mechanical properties composed of different hydrogel con-
centrations could be optimized to mimic the mechanical prop-
erties of the native ECM of nasal cartilage to allow for nasal 
cartilage tissue formation.
To integrate olfaction (biosensing based on OR immobi-
lization) and odor sensing (e.g., biosensing using peptides 
and aptamers) into the 3D-printed cartilage tissue constructs 
while preserving biological culture conditions, EC-based bio-
sensing presents an applicable choice with advantages such 
as high sensitivity, label-free detection, a wide linear detection 
range, and excellent detection limit. Additionally, EC-based 
biosensors possess flexibility in detection ability; for instance, 
the sensor can be conveniently functionalized with odorant 
receptor proteins to detect a wide range of human-detectable 
odors and chemicals. Furthermore, scalability and ease of min-
iaturization of the EC-based biosensors on various substrates 
(e.g., glass, paper, flexible polymeric substrates, etc.) facilitate 
their integration into live tissues and organs. In this paper, the 
biosensing mechanism is based on label-free EC impedance 
spectroscopy (EIS) to further improve sensitivity and circum-
vent acute cytotoxicity issues induced through labeling odorant 
receptors with electrochemically active specific molecules. 
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Nonetheless, common electrolytes, such as potassium ferricya-
nide (K3Fe(CN)6), are often toxic to cellular environments and 
affect cell-laden system viability. To operate the biosensor under 
biological culture conditions, we employ a culture media-
based electrolyte system with a weak and nearly negligible 
EC redox activity, lower conductivity compared to K3Fe(CN)6, 
but adequate sensitivity to pico-level concentrations of the 
analyte.[18] Developing such cytocompatible biosensors can 
open a pathway toward augmented sensing in hybrid organs; 
for instance, it is possible to functionalize the system with air-
borne pathogenic biomarkers,[19] volatile disease metabolites,[20] 
or odorless contaminants,[21] and thus achieve a cyborg olfactory 
organ. Such a bionic nose can prove useful in applications such 
as the detection of explosives, illegal drugs, or food poisoning.
2. Results and Discussion
2.1. Mechanically Tunable Dual Bioink System
The dimensions of common self-standing cell-laden 3D-printed 
constructs often do not exceed few centimeters. Several studies 
that created constructs beyond a few centimeters tall faced 
problems, such as losing the precision in geometry as short as 
a few minutes after printing, due to the swelling or low stiff-
ness of the bioink.[22] To overcome this challenge, one solution 
is to increase the viscosity or stiffness of the bioink to enhance 
the printability and reduce swelling.[23] However, in many 
cases, increasing the bioink stiffness results in reduced cell 
viability and proliferation imposed by the physical constraints 
of the now stiffer matrix.[24] Consequently, the trade-off between 
geometry precision and cell behaviors remains an ongoing 
challenge. To overcome this challenge, two distinct bioinks 
with stiff and soft mechanical properties were used to form a 
mechanically robust and biocompatible 3D-printed construct to 
support cartilage cell growth and differentiation within desired 
geometries. To enable two distinct mechanical properties 
within a single printed construct, we employed a multi-material 
3D bioprinting technique to create a self-standing 3D hybrid 
platform with desired stiffness and geometries (>1.5 cm height 
of printed constructs). Figure 1 shows the procedure for fabri-
cation of the hybrid nasal cartilage using a dual nozzle printing 
system. In the current study, a combination of GelMA and 
PEGDMA was employed to create a viable scaffold supportive 
of cartilage regeneration while being capable of maintaining 
the geometry of the structure even weeks after culture. High 
hydrophilicity, biocompatibility, and considerably low immuno-
genicity are some of the features of the mentioned polymers.[25] 
Owing to the reversible thermal gelation of GelMA pre-polymer 
solutions, the viscosity of the bioinks can be further reinforced 
prior to printing through physical gelation. Post-printing chem-
ical crosslinking can be achieved through photo-crosslinking 
with UV light.
Two bioinks consisting of different compositions of 
PEGDMA and GelMA were selected and denoted as “soft” and 
“stiff,” with the latter containing higher concentrations of each 
material. The former promotes cell adhesion and creates a suit-
able stiffness for chondrocyte growth while the latter creates a 
Adv. Sci. 2019, 1901878
Figure 1. Schematic diagram showing the procedure of printing the nose. The soft ink including the chondrocyte-laden solution and the stiff ink are 
both loaded in the printer. Afterward, dual printing is performed on top of the microfabricated sensor functionalized with a TNT-specific peptide. This 
hybrid system can be tuned to detect a range of targets such as natural odors, airborne pathogens, and odorless explosives.
www.advancedsciencenews.com
1901878 (4 of 15) © 2019 Brigham and Women’s Hospital/Harvard Medical School. Published by 
WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
www.advancedscience.com
structural scaffold to retain the shape and higher stiffness for 
mechanical strength. Following pre-polymer solution prepara-
tion, the soft ink was mixed with the cells to create a cell-laden 
bioink, while the stiff ink was prepared and printed in the orig-
inal acellular conditions. Addition of sacrificial biomaterials, 
such as gelatin, to the pre-polymer solution of both inks allowed 
for improved printability and a geometrically defined structure 
post-printing. Later the gelatin was dissolved from printed con-
structs during cell culture processes. To develop two different 
soft and stiff bioinks, we first tested the printability of bioinks 
with various combinations of gelatin, GelMA, and PEGDMA, 
reaching good printability. At the same time, we fabricated bulk 
hydrogels and then measured the mechanical properties (data 
not shown). We then selected two different compositions of soft 
and stiff bioinks: 5% GelMA/5% PEGDMA/6.5% gelatin and 
8% GelMA/10% PEGDMA/3% gelatin, respectively. We con-
firmed two distinct levels of mechanical stiffness for crosslinked 
soft and stiff bulk hydrogels as 20.3 ± 1.1 and 67.3 ± 1.1 kPa, 
respectively (Figure S1a, Supporting Information). The fracture 
point of stiff bulk gel was found to be 125 kPa at 50% strain, 
five times higher than the soft bulk gel. In addition, the micro-
structures of soft and stiff crosslinked bioinks were observed 
by scanning electron microscopy (SEM), and were found to be 
micro-porous structures. However, while the soft gel tended 
to easily collapse during the freeze-drying process due to its 
weak mechanical stiffness, the stiff gel was able to maintain its 
micro-porosity (Figure S1b,c, Supporting Information).
To understand and characterize the temperature-sensitive 
and fluidic behavior of each ink, the physical properties of the 
pre-polymer solution of soft and stiff bioinks were measured. 
Due to the temperature-dependent sensitivity of the gelatin 
and GelMA pre-polymer solutions, the viscosity of the inks was 
directly influenced by temperature, resulting in the creation of 
straight fibers and a more precise geometry under 19 °C and 
highly reduced printability above 27 °C (Figure 2a). Therefore, 
the incubation time for each ink required careful optimization 
to reach suitable printable viscosity between 17 and 22 °C. Fre-
quency sweep measurements showed that both soft and stiff 
bioinks possessed appropriate rheological properties to be used 
in bioprinting. The higher storage modulus (G’ > G”) across 
the range of frequencies studied indicated gel-like behavior, and 
therefore, the bioinks’ suitability to hold the shape of the bio-
printed structures, especially for the stiff ink, in which G’ was 
nearly sevenfold greater than that of the soft ink (Figure 2b). 
Moreover, both inks presented a non-Newtonian shear-thin-
ning behavior, with the power law index (n) being < 1. Such 
an index value is favorable for bioprinting due to the capacity 
of the material in behaving as a fluid under high shear stress, 
allowing a smoother nozzle extrusion, and behaving as a rigid 
body under low shear, after bioprinting (Figure 2c and Table S1, 
Supporting Information).
Due to the lower viscosity of the soft ink, the extruded fiber 
was thicker compared to the stiff ink at the same printing speed. 
By adjusting the moving speed of the nozzle, the diameter of 
Adv. Sci. 2019, 1901878
Figure 2. Rheological properties of the soft and stiff inks. a) Temperature-dependent behavior of soft and stiff inks affecting the storage (G’) and loss (G”) 
moduli, thus printability of each ink (N = 3). b) Storage (G’) and loss (G”) moduli of soft and stiff inks across a frequency sweep (N = 3). c) Change of 
viscosity with increments of shear stress for both inks showing the shear thinning behavior of the inks (N = 3). d) Fluorescence imaging of dyed extruded 
fibers using the soft (red) and stiff (green) bioinks across a variation of nozzle printing speeds. The soft ink creates thicker fibers due to lower viscosity. 
e) Characterization of fiber diameter by nozzle printing speed for the extruded fibers shown in (d). The extruded fiber diameters ranged from 200 to 
480 µm for the stiff ink and 550 to 1200 µm for the soft ink with lower viscosity (N = 4). f) Printability of the GelMA and gelatin optimized for printing.
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the extruded lines was optimized to reach similar printability in 
both inks (Figure 2d,e). Speeds higher than 24 mm s−1 resulted 
in breakage in lines and thus loss of printability. Therefore, 
we chose 18 mm s−1 for the soft ink nozzle and 6 mm s−1 to 
print the stiff layers. The air pump pressure was kept constant 
around 30 kPa for both inks. The diameter of the extruded fiber 
using stiff ink ranged from 200 to 480 µm while the soft ink 
with lower viscosity exhibited a higher extruded fiber diam-
eter range (≈550 to ≈1200 µm). As such, the diameters of the 
extruded fibers in the mentioned optimized nozzle speeds were 
found to be around 800 µm for the soft layers and 400 µm for 
the stiff layers. Moreover, by adjusting the gelatin to GelMA 
ratio in ink compositions, the printability of the inks was opti-
mized to create continuous fibers without needle blockage 
(Figure 2f).
Since the cell-laden layers require delivery of oxygen and 
nutrients through the thick printed construct, the permeability 
of the constructs had to be adjusted to allow for the circulation 
of nutrients and oxygen. We modified the printing parameters 
such as 3D slicing and infill ratio of the geometry to create a 
macro-porous structure without compromising the shape integ-
rity after printing and during culture. Using a 15–20% infill 
ratio in slicing the 3D model into layers met both criteria. After 
optimizing the printing parameters, the PEGDMA and GelMA 
pre-polymer chains in the printed constructs were crosslinked 
and solidified upon UV radiation. Figure 3a depicts the 
crosslinking procedure of the bioinks. Moreover, the formation 
of covalent bonds between the GelMA and PEGDMA among 
the layers helped to avoid any lamination issues between the 
stiff and soft printed layers despite their dissimilar mechan-
ical properties. As a result, a multi-layered cube composed of 
soft (red) and stiff (green) printed gel layers could be obtained 
(Figure 3b). Comparing the 3D computer-aided design (CAD) 
model dimensions with those of the 3D-printed product, we 
observed a 21% increase in the area accompanied with a 3% 
reduction in height before swelling the printed construct in the 
biological media. Assuming that both the stiff/soft hydrogels of 
the printed construct swelled in all three dimensions and the 
effects of swelling and collapsing could be superposed, we can 
conclude that the original collapse of the gel was around 18% 
of the original height. This reduction could be pertained to a 
greater collapse in the soft layers than that of the stiff layers 
as a result of low stiffness and less crosslinking density of the 
soft hydrogel. Also, gravitational forces of thick whole con-
structs might lead to the closure of internal pores in the soft 
hydrogel.[26] We then tested the printed constructs with various 
ratios of soft and stiff printed layers in terms of structural integ-
rity and mechanical properties (Figure 3c–f). In terms of the 
effect of the printing process on the mechanical properties, the 
existence of print infill relatively reduced the stiffness of fully 
stiff (0:1) and fully soft (1:0) printed constructs with ≈57 and 
≈3 kPa Young’s modulus, respectively (Figure 3f) compared to 
the nonprinted bulk crosslinked gels (≈20 kPa, soft and ≈67 kPa, 
stiff; Figure 3g and Figure S1a, Supporting Information). This 
reduction happened due to the creation of larger cavities within 
the microgrid structure as well as the propagation of cracks on 
the edge of the printed lines which caused breakage. Due to the 
presence of infill and patterned cavities in all printed constructs, 
the Young’s moduli of the printed constructs were not directly 
comparable with those of bulk gels. Therefore, an “infill factor” 
was introduced to all obtained Young’s moduli to normalize the 
printed constructs by the nominal print area, actual area, and 
weight of the printed samples. More specifically, fully stiff (0:1) 
and fully soft (1:0) printed constructs were normalized by their 
bulk gel counterparts through calculating the approximate den-
sity of each construct using the measured weight and dimen-
sions. Next, two infill factors were obtained for the fully soft and 
fully stiff hydrogels (i.e., soft infill and stiff infill). Composite 
infill factors for 1:1, 1:2, and 2:1 were introduced by composing 
different ratios of fully stiff and fully soft infill factors (e.g., 1:1 
infill was made with (1X soft infill+1X stiff infill)/2).
By increasing the soft:stiff ratio, or in other words, increasing 
the number of stiff layers, higher geometrical accuracy and 
mechanical properties can be obtained. For instance, fully 
stiff (0:1) hydrogels showed a significant difference in Young’s 
modulus compared to the composite hydrogels (1:0, 1:1, and 
1:2). This tunability can be especially useful for 3D-bioprinted 
constructs with complex printing patterns and nozzle move-
ments in all X-, Y-, and Z-directions, namely, those in a 3D 
nose model. However, increasing the overall stiffness of the 
constructs can inhibit the growth and ECM secretion of the 
cells. In this case, using higher soft:stiff ratios would provide a 
more appropriate substrate for chondrocyte growth. Mechanical 
compression tests on the samples with different soft:stiff ratios 
proved no significant difference between the Young’s mod-
ulus of 1:0, 1:1, and 1:2 ratios. However, the Young’s modulus 
increased significantly between 2:1 and 1:2 ratios. As a result, 
the (1:2) ratio was selected to create a composite construct with 
structural integrity while at the same time providing mechan-
ical properties comparable to those of the ECM required for 
chondrocyte growth and cartilage development. Although 
the mechanical stiffness of the native mature nasal cartilage 
matrix was reported as 100–400 kPa,[27] studies have shown 
greater chondrocyte maturation and high cartilage matrix dif-
fusion in engineered tissues with lower mechanical properties 
(10–30 kPa) compared to the native cartilage.[16,28] For instance, 
a recent study by Levett et al. showed that GelMA–hyaluronic 
acid (HA)–chondroitin sulfate (CS) scaffolds with mechanical 
properties ranging from 20 to 40 kPa can induce chondrogenic 
differentiation and high production of cartilage ECM including 
collagen II (COLII) and glycosaminoglycan (GAG) content. 
Moreover, embedding chondrocytes in the composite GelMA-
HA-CS scaffolds led to a significant increase in mechanical 
properties up to 150 kPa after 8 weeks of culture. It is hypoth-
esized that optimizing initial conditions such as large pore 
sizes and proper initial mechanical properties can lead to a 
large matrix secretion and higher mechanical properties in the 
engineered cartilage-like tissues over longer culture periods. 
As such, it is suggested that initially softer constructs can 
transform to the stiffest ECM over time more effectively than 
initially stiff hydrogels, since the latter can impede the forma-
tion and dispersion of the new ECM produced by the cells.[29]
Nonetheless, the degradation test of the printed construct 
with 1:2 ratio confirmed that structural integrity was preserved 
even after 17 days of culture while the final stiffness was 
enough to provide a suitable growing environment for the cells 
(Figure 3h). The percentage weight loss of the GelMA-PEG-
gelatin acellular constructs was caused by both dissolving of 
Adv. Sci. 2019, 1901878
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gelatin and degradation of GelMA chains at 37 °C upon incu-
bation. GelMA polypeptide chains were chemically crosslinked 
via conjugated methacrylate groups, however, most of the pep-
tide bonds in the GelMA polypeptide chains could be broken by 
hydrolysis from salt ions existing in a water-based solvent (ea. 
biological media) combined with an elevated temperature of 
around 40 °C.[30] In terms of cell-laden structures, the protein 
structure of the GelMA hydrogels permits cells to enzymatically 
degrade and remodel the gel for cell spreading and expanding 
in the degraded spaces.[31] Moreover, by tuning the UV inten-
sity, the printed construct could obtain a tunable range of 
degradation properties as well as maintain its shape integrity 
to minimize weight loss (Figure S2, Supporting Information). 
Increasing the crosslinking intensity resulted in a higher elastic 
modulus, however, exceeding 150 mW cm−2 led to the reduc-
tion of cell viability due to the release of free radicals as well as 
Adv. Sci. 2019, 1901878
Figure 3. a) Schematic of each ink composition after the UV crosslinking procedure and 37 °C incubation. The dots represent crosslinked sites upon 
UV exposure. The stiff inks include more crosslinked sites due to higher GelMA concentration. After incubation at 37 °C, the gelatin is dissolved, leaving 
the construct with a porous structure. b) A cube printed with soft (red) and stiff (green) inks (1:1) and crosslinked at 150 mW cm−2. c) Different ratios 
of soft (red) to stiff (green) were selected and tested. (2:0) and (0:2) represent the softest and stiffest constructs, respectively. d,e) Stress–strain curve 
of the different print ratio composites depicted in (c). f) Young’s modulus of the printed composite constructs (N = 4). g) Young’s modulus for soft 
and stiff bulk gels (nonprinted). h) Percentage of weight loss in the hydrogel samples during the 17 day culture. The UV crosslinking intensity was 
optimized to reduce the degradation rate and 300 mW cm−2 represents the least degradation. i) One of the cubes crosslinked at 100 mW cm−2 before 
(top) and after (bottom) degradation within the 17 day culture. Scale bar is 5 mm. j) SEM imaging of printed soft (i,ii) and stiff (iii,iv) gels. Red line 
indicates the printed fiber edge. Scale bar is 200 µm.
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possible damages and mutations in the cell DNA (Figure S3, 
Supporting Information). The optimal UV intensity for simul-
taneous targeting of structural integrity and high cell viability 
was found to be 100 mW cm−2 with an exposure time of 80 s 
at an 8 cm distance from the light source. Figure 3i shows the 
degraded hydrogel constructs crosslinked at 100 mW cm−2 on 
day 1 and day 17 of culture at 37 °C. By incubating the structure 
at 37 °C after UV crosslinking, the gelatin was removed from 
the structure and dissolved in the culture media. As a result, 
a highly microporous structure was achieved, as confirmed 
by SEM imaging (Figure 3j). Interestingly, printed hydrogels 
maintained a relatively higher porous structure compared to 
bulk crosslinked gels (Figure S1b, Supporting Information). 
This event can be pertained to the local chemical and physical 
crosslinking of the extruded fibers as exposed to the printer 
halogen light and lower temperature of the bed, thus creating 
a structurally robust construct. As seen in Figure 3j-i,ii, the 
printed soft layers maintained a highly porous structure with 
larger pore sizes compared to the stiff layers (Figure 3j-iii,iv, 
thus promoting the perfusability of the constructs.
2.2. A Supportive Microenvironment for Chondrocyte  
Culture and Growth
After optimizing printing parameters, cell-laden bioinks were 
characterized to study the feasibility of cell growth and func-
tionality in the multi-material printed structure. Chondrocytes, 
a representative cell type composing the nasal cartilage, were 
cultured and encapsulated in the soft bioink for cell-laden bio-
printing. A major challenge in expanding the primary chondro-
cytes in conventional 2D monolayer dishes has been the loss 
of chondrogenic phenotypes and the occurrence of “dedifferen-
tiation” after a few passages. Dedifferentiation of chondrocytes 
is often followed by the gradual decay of chondrocyte-specific 
molecular markers such as GAGs, aggrecan (ACAN), and 
COLII.[32] At this stage, chondrocytes would lose the original 
rounded morphology and tend to a more extended fibroblast-
like morphology.[33] Several studies have proven that “re-dif-
ferentiation” can be achieved by embedding and culturing 
the chondrocytes in high-density 3D gel suspensions such as 
agarose,[34] alginate beads,[35] or 3D collagen-based matrices.[36] 
Moreover, the chondrocyte markers such as COLII deposition 
are shown to be restored through 3D culture. In the present 
study, the printing and culture of the encapsulated chondro-
cytes in the GelMA-based soft bioink led to the maintenance of 
a typical rounded morphology in the chondrocytes (Figure S4, 
Supporting Information). The presence of RGD (Arg-Gly-Asp) 
binding sites in the GelMA hydrogel was previously shown to 
enable high cellular adhesion.[37]
The 3D-printed constructs composed of cell-laden soft 
and stiff printed layers can be a suitable scaffold for seeding 
and encapsulation of chondrocytes to improve chondrogenic 
behavior in 3D and to promote the deposition of cartilage ECM. 
We first encapsulated the chondrocytes in the soft bioink and 
printed the multi-material construct using the cell-laden soft 
ink and acellular stiff ink in a dual nozzle printing process 
(Figure 4a). Next, the cell-laden constructs were allowed to sta-
bilize and were cultured in vitro for 2 days. To enhance the cell 
viability and increase the cell density throughout the macroscale 
construct, additional amounts of chondrocytes were seeded on 
the printed constructs on day 2 of culture post printing. Seeding 
the chondrocytes on the printed constructs also allowed for 
higher cell signaling and interconnectivity across the con-
struct. The printed constructs cultured with encapsulated cells 
sustained a high cell viability and adhesion to the biomaterial 
even after 30 days of culture in vitro (Figure 4b–d). The viability 
of encapsulated chondrocytes in the soft bioink was found to 
be approximately 80% on day 1 due to the loss of a fraction 
of cells to shear stress and the lack of cell culture conditions 
(Figure 4d). However, the cells recovered within 7 days of 
printing to an average viability of 95%. To perform the viability 
assay such as to be able to compare the values on day 1 and 
day 7 regardless of the effect of the seeding process, no cells 
were seeded in these constructs. Moreover, the encapsulated 
cells in the innermost layers of the constructs showed original 
rounded chondrocyte morphology (Figure S4a,b,d, Supporting 
Information) as opposed to the highly elongated morphology 
often observed in 2D cultures (Figure S4c, Supporting Infor-
mation). Moving from the innermost to the outer layers of the 
constructs, the encapsulated cells gradually showed a relatively 
elongated morphology with a higher area of phalloidin (F-actin) 
expression (Figure 4b,c). In terms of seeded cells on the printed 
constructs, Figure 4e,f shows the 3D reconstructed confocal 
images of cell morphologies cultured on the thick printed 
construct after 30 days. Accordingly, the cells covered the 3D 
construct along the printed fibers, creating a fully cellular 
macro-scale viable construct. Moreover, the metabolic activity 
study of the cell-laden printed and seeded constructs exhib-
ited an increase over the course of 14 days (Figure 4g). The 
constructs were re-plated after seeding and during culture to 
avoid media consumption by the excess cells migrating to the 
outside environment of the constructs and those attaching to 
the bottom of the plate. Therefore, the results of the metabolic 
assay were recorded merely based on the cells inside or on the 
constructs. Supplementing the chondrocytes with L-ascorbic 
acid can promote COLII and GAGs deposition and lead to 
the effective differentiation of chondrocytes.[38] Expression of 
COLII in the printed constructs supplemented with L-ascorbic 
acid was observed after 14 days of culture (Figure 4h,i). The 
amount of collagen deposition decreased by moving from the 
edges of the constructs to inner sections (Figure 4j). This reduc-
tion can be pertained to the reduced delivery of L-ascorbic acid 
and nutrients to the inner parts of the printed construct. In 
conclusion, the soft gel exhibited a supportive platform for 3D 
culture of chondrocytes.
2.3. Integration of the Biosensor and Hydrogel
The next step after optimization of the printing and chon-
drogenic maturation was creating the hybrid nose structure 
coupled with the sensing capability. As such, a CAD file of 
the nose was modified to include open nostril cavities for bio-
sensor embedding (Figure 5a–c). Printing the convex geometry 
of nose models along with nostril cavities required a relatively 
convoluted printing pattern with both convexities and concavi-
ties. The ink ratio of soft:stiff was therefore optimized to 1:2 
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to create a free-standing nose to minimize the final structural 
(total layers: 10) collapse to less than 3% and to achieve geomet-
rical integrity while maintaining porosity for nutrient perfusion 
as well as maintaining a chondrocyte-supportive ECM through 
the soft layers. Next, the dual ink cell-laden nose was printed on 
top of two functionalized sensors while the sensor chambers 
were left exposed (Figure 5a,d). To better illustrate the multi-
material printing of the nose using color contrasting, the nose 
in Figure 5c was printed using a 1:1 ink ratio (stiff layers shown 
in green and soft layers in red).
Interfacing tissues with electronics is still hampered by bio-
compatibility and cytotoxicity caused by the highly conductive 
but toxic elements used in the biosensing components, espe-
cially for the electrode materials and electrolytes. As such, it 
is essential to develop and optimize the biosensors in a cell-
friendly environment where the target biomimetic organ can 
remain viable while the functionality is maximized. Several 
groups have attempted to solve this issue by fabricating bio-
compatible electroconductive substrates such as graphene, 
carbon nanotubes, poly(3,4-ethylenedioxythiophene):polystyrene 
sulfonate (PEDOT:PSS), and gold (Au) to provide a minimally 
toxicogenic environment for the integrated cell-laden system.[39] 
To achieve our aim, a metal-based three-microelectrode system 
with a working electrode (WE, Au), counter electrode (CE, 
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Figure 4. Characterization of cell-laden ink during in vitro culture. a) Schematic diagram of cell integration in the bioprinted construct. b,c) Confocal 
images of 3D soft gels immunostained with F-actin/DAPI on day 10 and day 30 of culture. The scale bars in the insets are 50 µm. d) Cell viability after 
printing shows a small decrease but the cells revive until day 7 (N = 3). e,f) 3D reconstruction of Z-stack images of the printed construct. The thickness 
of the scanned layers is 890 µm. Scale bar in the phase contrast image is 200 µm. g) PrestoBlue assay to analyze the metabolic activity of the cells in 
the cell-laden and cell-seeded printed constructs over the course of 10 days of culture in vitro (N = 4, *p < 0.05, **p < 0.01). h,i) COLII staining and 
confocal imaging of soft ink layers on the edge of (h) and inside (i) the gel after 20 days of culture. Scale bar in the inset image is 50 µm. j) Percentage 
of collagen production per cell decreased slightly from the edge of the printed construct into the inner layers of the hydrogel. The fluorescence intensity 
of the confocal layers was measured and the ratio of this intensity to total numbers of DAPI gave out the percentage of collagen deposition per cell.
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Au), and reference electrode (RE, silver, Ag) was of specific 
interest for fabricating a robust EC biosensing system due to 
its decent stability, beneficial electron-transfer kinetics, and 
capability to covalently bind with various chemical functional 
groups, namely, thiol-based structures.[40] In addition, to fab-
ricate biocompatible microelectrodes, an e-beam deposition 
method was selected to avoid using any toxic organic chemicals 
or compounds compared with other microfabrication methods. 
To evaluate the cytotoxicity of the electrode materials (Au and 
Ag), chondrocytes were seeded on the bare microelectrodes 
and their viability was analyzed. Using Au as a highly bio-
compatible conductive substrate, we observed 97.7 ± 1.3% cell 
viability (Figure 5e–g). The Ag RE showed decreased viability 
(79.7 ± 1.0%) compared with that of the Au electrode. However, 
the cytocompatibility of the Ag electrode was still good enough 
to allow for cell growth and proliferation after 7 days of culture 
as confirmed by F-actin staining (Figure 5h).
2.4. Biosensing Explosive Molecules
EIS is a label-free detection method which has recently been 
employed as a fast and reliable way to detect a myriad of 
chemical odors, airborne pathogens, and biomarkers with high 
sensitivity.[41] Similar to the sensing mechanism in the olfac-
tory epithelium, the EIS system can be functionalized to mimic 
the odor binding mechanism by creating a sensing platform 
similar to that performed through nasal mucus. We employed 
this detection method to develop a biosensing component for 
the hybrid nose (Figure 6a). The method of fabrication and 
functionalization was developed and discussed in detail in a pre-
viously published paper where an Au-based microelectrode was 
used as a highly conductive and effective substrate for label-free 
monitoring of cell secretomes from in vitro cultured tissues.[41c]
Au-based biosensing provides high flexibility in biosensor 
functionalization with a variety of natural or synthetic recep-
tors to detect a wide range of chemical structures including 
explosives and human-imperceptible biomolecules. Real-time 
in situ detection of explosives is considered a major demand 
for security purposes and environmental concerns. Therefore, 
timely and sensitive detection of such chemicals can prevent 
a number of unfavorable and destructive events such as mine 
site blast injuries caused by explosive debris post explosion.[42] 
2,4,6-Trinitrotoluene (TNT) is one of such prevalent explosives 
used for various industrial practices which can be captured and 
sensed using the EIS system. We tested the biosensing system 
with TNT using a TNT-specific peptide chain (EPQLKM) devel-
oped in a previous paper.[43] The mechanism of detection in 
the EIS-based sensing system is premised on changes brought 
on by the interfacial electron transits between the redox probe 
[Fe(CN)6]4−/3− and the substrate electrode upon creation of 
specific bonds between the antibody (here, TNT-specific peptide) 
and the antigen (TNT).[44] At a specific range of TNT concentra-
tions, the amount of TNT captured by the receptor antibodies 
functionalized on the sensor corresponded to those present 
in the solution, and could be characterized via recording the 
electrode impedance.[44] Therefore, we obtained the Nyquist 
curves in frequencies ranging from 10−1 to 105 Hz (potential 
0.10 V, and modulation amplitude, 5 mV) using a 50 × 10−3 m 
K3Fe(CN)6 electrolyte solution. As shown in Figure 6b, upon 
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Figure 5. Integration of the biosensing system with the 3D-printed construct. a) Dual ink nozzles printing a nose on top of the sensor electrodes. 
b,c) CAD 3D drawing of the nose with dual ink layers (top) and the printed construct using the same code (bottom). d) Optical image of the microfab-
ricated Au biosensor with three electrode sensing system (top) and 3D-printed dual-ink nose integrated with the biosensors in each nostril (bottom). 
e,f) Live/dead assay images of chondrocytes seeded on the biosensor to test biocompatibility on Au (e) and Ag (f) electrodes. g) Quantified cell viability 
graph on Au and Ag electrodes on day 1 after integration with cells. h) F-actin/DAPI staining of the sensor 7 days after integration.
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functionalization of a self-assembled monolayer (SAM) and 
blocking media solution on the sensor, a significantly larger 
semicircle was seen in the high-frequency region compared 
to the bare signal. Nonetheless, the signals recorded at low 
frequencies (i.e., Warburg impedance) were shown to be elimi-
nated compared to the bare sensor signal. Subsequent function-
alization of the sensor with analytes led to the binding of new 
molecules to the sensor surface, thus increasing the insulating 
layer between the probe and the electron transit. As such, the 
impedance at each functionalization step showed an increment 
compared to the former step (Figure 6b). Similarly, the diam-
eter of the Nyquist semicircle (i.e., electron transfer resistance, 
Rct) at each step was also increased by immobilizing new layers. 
Next, the impedance was measured before and after the expo-
sure of TNT molecules to the biosensor (Figure 6c,d). Similar 
to the receptor immobilization steps, exposing higher concen-
trations of TNT to the sensor led to the capture of more TNT 
molecules by the sensor and thus an increase in the recorded 
impedance and Rct values. The results proved that the system 
can detect a range of 1–1000 pg mL−1 of TNT (Figure 6e). In 
addition, the biosensor exhibited capability to detect TNT 
with a limit of detection of 0.38 pg mL−1 with a sensitivity of 
8.6 (log(ng mL−1))−1. Recently, Gao et al. implanted a TNT-
receptor functionalized bioelectronic nose sensor in the green 
fluorescent protein-labeled olfactory sensory neurons (OSNs) 
of transgenic mice, showing detection sensitivity of up to 
10 × 10−6 m TNT in vivo (11 ng mL−1).[45]
Potassium ferrocyanide (K3Fe(CN)6) is a common electro-
lyte mediator used for the EIS-based measurements due to its 
strong redox activity.[46] However, exposure of such electrolytes 
to cells and biological systems can cause cytotoxicity and lead 
to erroneous cell behavior.[18] One solution to this problem is 
to seclude the measurement chamber from the incubation 
platforms to avoid direct cell contact with K3Fe(CN)6 .[47] This 
solution, however, would not fit the purpose of a hybrid bionic 
nose which aims to monitor and measure the analytes in real-
time continual monitoring after being integrated with the 
engineered tissue. As an alternative, the biocompatibility of the 
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Figure 6. Biosensing mechanism and procedure. a) Schematic diagram of the functionalization procedure of the biosensor using the TNT-specific 
peptide. b,c) Nyquist plot of measurement using different concentrations of TNT, sensing using ferrocyanide. Upon capturing TNT by the peptide, 
impedance increases in the ferrocyanide-based measurement system. d) Bode plots using 0.1–1000 pg mL−1 TNT, sensing using ferrocyanide. Plots 
(c) and (d) share the same legend. e) Calibration curve for TNT sensing using ferrocyanide. f) Nyquist plots of measurement using 10 pg mL−1 of TNT, 
sensing using culture media. g) Bode plots using 0.1–1000 pg mL−1 TNT, sensing using culture media. h) Calibration curve for TNT sensing using cell 
culture media. i) Diagram of degradation of TNT peptide over 8 days of incubation at 37 °C.
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system can be increased through changing the mediator elec-
trolyte to a biocompatible nontoxic platform such as chondro-
cyte culture media (Figure 6f,g).[18] As an initial step, we tested 
and compared the impedance response of the bare electrode 
to Dulbecco’s phosphate buffer saline (PBS) and cell culture 
media, which contain ≈150 × 10−3 m salts and have an electrical 
conductivity of ≈1.5–2 S m−1 (Figure S5a,b, Supporting Infor-
mation).[48] However, in PBS and culture media, the semicircle 
curve disappeared due to the lack of or weakness of a redox 
reaction. The magnitude of the impedance recorded from the 
bare electrode in K3Fe(CN)6 was found to be 1000 times lower 
than PBS and culture media due to the relatively high resist-
ance of media and PBS compared with that of K3Fe(CN)6. Next, 
the sensor was functionalized with an EPQLKM peptide and 
the results were measured in media and compared to those 
measured in the presence of K3Fe(CN)6 (Figure 6f–i). To com-
pare the impedance (Z) values at any arbitrary frequency, such 
values can be extracted and drawn for different functionaliza-
tion steps. As an example, we chose 2.09 Hz to compare the Z 
values of the sensors. As seen in Figure 6g, the impedance at 
2.09 Hz follows an increasing trend upon increasing the con-
centration of TNT from 0.1 to 1000 pg mL−1. The calibration 
curve was calculated based on the different concentrations of 
TNT measured in media (Figure 6h). As a result, the sensitivity 
of the sensor was found to be 0.1 pg mL−1.
Considering that the developed hybrid system needs to be 
functional after days of culture at 37 °C, it is important to ensure 
that the functionalization of the sensor is not disturbed by the 
culture duration and environmental factors. Therefore, we per-
formed a degradation test to confirm that the peptide can stay 
viably active in the culture environment for up to 8 days after 
printing and before being degraded (Figure 6i and Figure S5c, 
Supporting Information). The results proved that the peptide 
can stay active for up to 5 days after functionalization. After-
ward, the gradual degradation of functionalized layers occurred, 
and the peptide coating layer was gradually destroyed from the 
substrate, leading to an impedance reduction to a value lower 
than the blocking stage. Therefore, for prolonged sensing, the 
sensor should be functionalized again or replaced by a new 
electrode after 5 days.
Consequently, the hybrid construct exhibited a potential to 
detect secretions of bioactive targets and disease biomarkers in 
humid mucus conditions. In later works, the detection mecha-
nism can be fitted to provide biosensing in an integrated engi-
neered mucus. Although the proposed approach introduces a 
different method for the integration of electronics with bioma-
terials, several challenges need to be addressed to reach a fully 
functional reconstructed nasal organ. For instance, embedding 
engineered co-culture systems of neural and endothelial net-
works into the hybrid devices could be a first step toward com-
pensating for the absence of vasculature and nerves in the thick 
printed constructs as opposed to the native organ.
Moreover, full retention of the human olfactory system 
requires the culture and integration of hundreds of ORs, combi-
nations of which drive the smell recognition in the native olfac-
tory epithelium.[49] Although the emergence of the bioelectronic 
nose has pushed science toward artificial odor perception, 
there are still several challenges in reaching a full functional 
and implantable artificial nose. First, although the developed 
biosensors are capable of distinguishing their target odorants 
with high sensitivity and selectivity, they still fail to identify 
complex mixtures and reach a comprehensive odor perception 
system similar to that of humans.[50] In fact, the natural olfac-
tory-taste system is stimulated by the combinatorial pattern rec-
ognition of various ORs,[49,51] and thus, the activation of several 
ORs would lead to the perception of a specific odor or taste. To 
reach higher levels of complex odor perception, the bionic nose 
devices require the implementation of a complete set of natural 
ORs which would jointly contribute to differentiation of diverse 
smells. Further, to enable odor discriminatory function in 3D 
bionic noses, it is essential to convert the single-target bio-
sensing system into a multisensory array functionalized with a 
range of ORs and peptide receptors. Recently, a multiplexed bio-
sensor was proposed by Son et al.[50] that immobilized human 
ORs onto a multichannel carbon nanotube-based FET to ana-
lyze four types of taste- and odor-causing compounds produced 
by food. Implementing such sensors in our hybrid system 
can generate a tunability to detect other targets such as a wide 
range of complex human-perceptive odors using only a small 
OR matrix. In another study, an artificial multiplexed superbio-
electronic nose was recently introduced by Kwon et al. to mimic 
the human odor discrimination in mixtures by functionalizing 
micro-patterned graphene FETs with human ORs.[5h] Toward 
augmented detection of the bioelectronic nose through multi-
plex biosensing, Peveler et al. have developed a multichannel 
quantum dot array to detect five explosives including TNT up 
to 0.2 µg mL−1.[52] Lastly, a crucial step toward biomimicking 
human olfaction is to standardize bionic nose devices by cre-
ating a universal code for gauging odors. This procedure can be 
done by choosing a set of primary odor molecules to build up 
odor mixtures and patterns, similar to the role of three primary 
light colors in building a wide spectrum of lights.[53]
Creation of hybrid bionic noses may contribute to under-
standing the fundamental mechanisms employed by the 
natural olfactory system for reaching selectivity. Eventually, 
the developed hybrid nose could promote a minimally invasive 
diagnosis tool for airway diseases, such as imminent asthmatic 
attacks, through sensing the airborne biomarkers in the breath. 
Moreover, 3D-bioprinted hybrid nasal constructs could be 
instrumental in development of “cyborg” organs which possess 
augmented functionalities over their native human counter-
parts. Lastly, the developed hybrid system may offer enhanced 
precision to nasal cartilage reconstruction strategies as well as 
reviving the olfactory sensation which is often permanently lost 
during traumatic injuries. Therefore, the hybrid nasal construct 
can provide a potential solution to the drawback of current rhi-
nectomy methods.
Being in its infancy, full nose organ retention still requires 
extensive studies and the addressing of several challenges. 
An artificial nose, which is to be implanted on the surface 
of the body, directly interacts with exogenous factors and the 
extrinsic environment, and thus cannot be fully maintained 
merely through the internal biological system for oxygen and 
nutrient supplementation, temperature regulation, and waste 
removal through blood circulation. A complementary external 
support is required to ensure the maintenance of environ-
mental factors for tissue survival, or else the implant would 
be transformed into a massive necrotic block. To address this 
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challenge, one solution is to add skin grafts on top of the arti-
ficial implant to isolate the organ from the outer environment 
and create uniform integration with the internal biosystem. 
This approach would require additional studies including the 
adhesion between the bionic nose implant and the skin graft.[54] 
To obtain effective and accelerated integration with the host 
body on the initial days of implantation, engineered nose con-
structs must be supplemented with an array of pre-vascularized 
networks which can connect with the host’s vascular system. 
Additionally, another approach to integrate skin grafts could be 
suggested by co-culturing the bionic nose with a skin-mimetic 
layer (i.e., artificial skin)[55] or 3D bioprinting a layer of tissue 
engineered skin on top of the bioprinted nose organ.[56] In 
such a case, the bionic skin would potentially provide environ-
mental necessities (e.g., temperature and humidity control, 
oxygen supply) for self-maintaining the implant in the initial 
few weeks as well as releasing specific biological cues to induce 
skin regeneration. Finally, full replication of the anatomy and 
function of the nose will require reconstruction of the native 
structural and cellular heterogeneity including but not limited 
to cartilage, bone, OSNs, epithelial layers, and vasculature. 
This step would require concurrent advancement and research 
in multiple areas of tissue engineering including neural, skin, 
bone, and cartilage engineering.
3. Conclusion
We introduced a new hybrid device consisting of a dual bioink-
printed nose construct with an integrated biosensing system. 
The multi-material printed construct consisted of several soft 
layers engineered for chondrogenic growth and adhesion, and 
multiple stiff layers with higher mechanical properties for pro-
moting the mechanical robustness and macroscale geometrical 
integrity. The cell-laden constructs supported chondrocyte 
growth and secretion of cartilage ECM after 14 days of culture 
in vitro. Moreover, the system showed capability in sensing 
TNT and could be further functionalized and tuned to detect 
a variety of natural odors, chemical structures, and disease 
biomarkers. The developed hybrid device lays the groundwork 
for a 3D-printed viable cartilage-like tissue with an integrated 
enhanced electronic olfactory system which can eventually 
become a viable humanoid cyborg nose organ. While these 
approaches can provide a more inclusive model of the native bio-
logical entities, they bring a myriad of new capabilities and novel 
applications in medicine, organ mimicry, and humanoid robotics 
by introducing controlled or even enhanced functionalities over 
the original biological functions. Lastly, future integration of a 
multiplex biosensing platform in the developed hybrid system 
and recapitulation of the multi-layered heterogenous structure of 
the nasal cartilage can be a potential pathway toward achieving 
full nasal regeneration and nasal implants in the future.
4. Experimental Section
Materials: Gelatin from porcine skin, PEGDMA (1000 k), L-ascorbic 
acid, and photo-initiator (PI) 2-hydroxy-4′-(2-hydroxyethoxy)-2-
methylpropiophenone (Irgacure D-2959) were purchased from Sigma-
Aldrich. Hanks’ balanced salt solution (HBSS), fetal bovine serum 
(FBS), PBS, and Dulbecco’s modified Eagle medium (DMEM) were 
purchased from Thermo Fisher Scientific. Medium degree GelMA was 
synthesized based on the previous protocols.[25b] Briefly, 10% w/v gelatin 
was dissolved in PBS at 50 °C. Afterward, 5% v/v methacrylic anhydride 
(Sigma-Aldrich) was added to the solution dropwise at a constant rate 
of 0.5 mL min−1. The reaction was mixed for 2 h. Next, PBS (40 °C) was 
added to the solution and the mixture was dialyzed (12–14 kDa dialysis 
membranes) at 40 °C for 7 days. The mixture was then placed at −80 °C 
for 2 days followed by lyophilization for 3 days. The resulting GelMA 
foam was stored at room temperature until use. SAM was prepared by 
dissolving 11-mercaptoundecanoic acid (11-MUA) (Sigma-Aldrich) in 
>99% pure ethanol (Sigma-Aldrich). N-(3-Dimethylaminopropyl)-N’-
ethylcarbodiimide hydrochloride (EDC), N-hydroxy-succinimide 98% 
(NHS), and potassium ferricyanide [K3Fe(CN)6] were purchased from 
Sigma-Aldrich. Ag epoxy glue (MG Chemicals) was used to connect the 
electrodes to the measurement system. A TNT-specific peptide sequence 
(EPLQLKMGGGGWFVI) was purchased from Peptide 2.0. Peptide was 
diluted in deionized (DI) water at a concentration of 1 mg mL−1.
Preparation of the Bioink: To prepare the soft ink, 5% GelMA (medium 
degree of MA), 5% PEGDMA, 6.5% gelatin, and 0.5% PI were used. For 
the stiff ink, 8% GelMA (medium degree of MA), 10% PEGDMA, 3% 
gelatin, and 0.5% PI were used. To prepare the soft ink, PEGMDA was 
dissolved in HBSS and incubated at 80 °C for 20 min. Next, the GelMA, 
gelatin, and PI were added to the solution and the vial was covered by 
aluminum foil and incubated at 80 °C for 30 min. The ink was then 
moved to the 37 °C incubator for 20 min before being added to the cells. 
The preparation of stiff ink began by dissolving the gelatin in DI water 
and incubating at 80 °C for 10 min. Afterward, GelMA and PI were added 
to the ink, covered by aluminum foil and incubated at 80 °C for 20 min. 
Next, the PEGDMA was mixed with the solution and incubated at 37 °C 
for 30 min. The inks were allowed to stabilize at room temperature. Soft 
ink rested for 15 min prior to printing and Stiff ink required 40 min at 
room temperature before printing. Both times were coordinated to reach 
printable conditions at the same time.
Mechanical Characterization: Compression stress tests were performed 
using a parallel plate platform (ADMET, MTESTQuattro). Samples with 
around 0.9 cm circular diameter and 0.5 cm thickness were loaded 
and tested until rupture. All measurements were performed at room 
temperature. Prior to all measurements, the zero gap was determined. 
Four samples of each condition were tested. For the printed samples, 
an infill factor was introduced to normalize all the samples based on 
the theoretical (in the g-code) and practical infill (after the print) by 
comparing the weights and strain of printed samples to bulk gels with the 
same dimensions. This infill factor was averaged and defined for the soft 
and stiff ink separately. For instance, to calculate the infill factor for 1:2, 
1X soft and 2X stiff were used. All results of the composite ratios were 
normalized by their corresponding infill factors (0:1, 1:1, 1:2, 2:1, 1:0 and 
0.89, 0.79, 0.75, 0.82, 0.68, respectively). To calculate Young’s modulus, 
the elastic part (10–20% strain) of the stress–strain curve was used.
Rheology tests were performed on a TA Instruments DHR-3 
rheometer. A 20 mm diameter parallel plate geometry was used for all 
measurements. Samples were approximately 500 µm thick and the gap 
size was approximately 500 µm in all cases. All rheological measurements 
except the temperature sweep experiment were performed at 25 °C. To 
measure the viscosity by sweeping the temperature, a temperature 
control attachment (PolyScience) was used. Prior to measuring each 
sample, the measuring system inertia of the upper geometry as well as 
the motor friction was calibrated. All samples were allowed for relaxation 
and reached equilibrium for 30 min after loading and before initiating 
the test. An amplitude sweep was done on the samples to determine 
the linear viscoelastic window at three frequencies, ω = 0.3, 1, and 
10 rad s−1, in 0.01–2% strain.
3D Bioprinting: 3D bioprinting was performed using a Cellink 
Inkredible bioprinter. A CAD file of a nose was sliced using Slic3r 
software to generate gcode readable by the bioprinter. The printing infill 
was chosen as 20% for both inks. A nozzle speed of 15 mm min−1 was 
used to print the final constructs. A 3 mL syringe (BD) and 27 gauge 
needle (Fisnar) were used for printing both inks. The nozzle was covered 
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by foil during the process to avoid random crosslinking of the gel. An air 
pump was used to create the extrusion force for the nozzle. The pump 
rate was adjusted to initiate the printing and then decreased to 40 kPa for 
the soft ink and 90 kPa for the stiff ink. UV crosslinking was induced using 
a OmniCure S2000 machine and a 5 mm diameter light guide UV lamp. 
The stage was adjusted to 8 cm distance from the light guide and the UV 
intensity was calibrated to 100 mM cm−2. All constructs were crosslinked 
for 80 s, flipping the construct carefully half-way through the process.
Fabrication of the Sensors: The sensors were fabricated at the Harvard 
Center for Nanoscale Systems. Ag RE, Au CE, and Au WE were created. 
After cleaning the square glass substrates (25 mm × 25 mm) with oxygen 
plasma, a shadow mask process was used in order to manufacture the 
microelectrodes (Figure S1, Supporting Information). In this process, 
metal layers were selectively deposited over a shadow mask which has 
apertures in a metal film of 0.25 mm thickness. In this process, the first 
shadow mask for WE and CE was attached to cleaned glass substrate. 
The 20 nm thick titanium (Ti), 20 nm thick palladium (Pd), and 500 nm 
thick Au were deposited on the glass using e-beam evaporation. Also, 
the Au electrodes were not patterned with a passivation layer. Next, the 
second shadow mask for RE was attached to the Au deposited glass 
wafer. The alignment was achieved by using alignment keys. 20 nm thick 
Ti, 20 nm thick Pd, and 500 nm thick Ag were then deposited. After 
peeling off the shadow mask from the wafer, the required patterns were 
realized without the need for any wet processing.
Sensor Functionalization to Detect TNT: The functionalization of 
the sensor followed the previously established protocol.[41c] Briefly, 
the surface of the sensor was first functionalized with SAM using 
11-MUA. Next, an EDC/NHS conjugation was coated on the sensor 
to create a covalent bond between the surface and SAM where the 
carboxylterminated alkyl surface was converted to an active NHS ester 
when reacting with 11-MUA. Next, the peptide was coated on the sensor 
at a concentration of 1 µg mL−1. Surface passivation was done using 
cell culture media. Dilutions of TNT were prepared in fresh cell culture 
media ranging from 0.1 pg mL−1 to 1.0 ng mL−1. The measurements 
were taken using K3Fe(CN)6 and cell culture media. In this case, the 
culture media was left at room temperature to reach pH equilibrium. 
Nyquist plots were obtained in the frequencies ranging from 10−1 to 
105 Hz under a potential value of 0.1 V and modulation amplitude of 
5.0 mV in 50 × 10−3 m K3Fe(CN)6.
Toxicity Test of the Biosensor: All sensors were washed with 70% 
ethanol followed by 30 min incubation at 37 °C with 1% Anti-Anti in PBS 
solution.
In Vitro Culture: Primary chondrocytes from 1 month old calves 
(Astarte bio) were cultured and passaged for 1 week at 37 °C and 5% 
CO2. DMEM, 10% FBS, and 1% p/s were used as the culture media. Cells 
were encapsulated in the bioink at a density of 20 million cells mL−1. 
Furthermore, additional cells with 0.5 million cells cm−2 were seeded 
on the constructs on day 2 of printing. After printing, the culture media 
was supplemented with 50 µg mL−1 l-ascorbic acid to induce collagen 
II production. To increase the cell viability during the printing process, 
the concentration of HBSS in the soft ink was adjusted to include 20% 
FBS added directly to the cell pellet before cell encapsulation (1:9 ratio 
of HBSS to FBS). The constructs were supplemented with media after 
printing and the media were changed every 2 days.
Cell-Laden Characterization: Cell viability and proliferation of the 
printed constructs were assessed using live/dead assay (Thermo 
Fisher scientific) and PrestoBlue kit (Thermo Fisher scientific). The 
colorimetric assays were measured using a plate reader (Infinite 200 pro, 
Tecan Austria GmbH) by measuring the absorbance at 570 nm with 
reference to 600 nm. The results were normalized by day 1 of culture. 
Fixation of cell-laden constructs was done on days 14 and 30. Briefly, 
the constructs were treated with 4% paraformaldehyde solution (Thermo 
Fisher scientific) for 30 min and then permeabilized using 0.1% Triton 
X (Sigma-Aldrich). F-actin (1:40, Invitrogen) and COLII antibody (1:100, 
Invitrogen) were added to the constructs for staining. The constructs 
were incubated with the primary antibody overnight on a mild shaker at 
4 °C. Secondary antibody goat anti-mouse Alexa Fluor 594 (Invitrogen) 
was used to image the COLII staining and was added to the constructs, 
followed by incubation at 4 °C for 6 h. DAPI (4′,6-diamidino-2-
phenylindole, 1:1000, Sigma-Aldrich) was added 30 min prior to imaging. 
Confocal imaging was performed using a Zeiss LSM 880 airyscan 
microscope. Images were processed and analyzed in Fiji software.
Statistical Analysis: All tests were performed in triplicates and the 
average and standard deviation were calculated in Graphpad Prism. The 
results of the PrestoBlue assay were analyzed using one-way analysis of 
variance method. Error bars represented mean ± standard deviation of 
measurements in each group. To compare different treatment groups 
and study the existence of significant differences among groups, Tukey’s 
multiple comparison method with p < 0.05 was employed. Statistical 
Significance in all graphs was indicated as not significant (ns) (p > 0.0.5), 
*(p < 0.04), and ****(p < 0.0001).
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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